PEGylation, the process of attaching polyethylene glycol (PEG) molecules to another compound, notably proteins or peptides, has gained considerable attention in the fields of biochemistry and ...

Ampersand Capital Partners has announced its acquisition of Nektar Therapeutics’ PEGylation reagent manufacturing business.

PEGylation enhances the stability, solubility, and half-life of therapeutic proteins, leading to better efficacy and fewer side effects. Additionally, advancements in biologics and increasing R&D ...